Xu RA - Search Results

1

Inhibitory effects of calcium channel blockers nisoldipine and nimodipine on ivacaftor metabolism and their underlying mechanism.

Xia H, Xu X, Chen J, Wu H, Shen Y, Chen X, Xu RA, Wu W. Xia H, et al. Among authors: xu ra. Front Pharmacol. 2024 Sep 12;15:1403649. doi: 10.3389/fphar.2024.1403649. eCollection 2024. Front Pharmacol. 2024. PMID: 39329117 Free PMC article.

2

Determination and Pharmacokinetic Profiles of Four Active Components From Scrophularia ningpoensis Hemsl. in Rats.

Luo S, Xie L, Chen J, Tang C, Xu RA. Luo S, et al. Among authors: xu ra. Front Pharmacol. 2021 Jan 13;11:612534. doi: 10.3389/fphar.2020.612534. eCollection 2020. Front Pharmacol. 2021. PMID: 33519478 Free PMC article.

3

In vivo Pharmacokinetic Drug-Drug Interaction Studies Between Fedratinib and Antifungal Agents Based on a Newly Developed and Validated UPLC/MS-MS Method.

Tang C, Niu X, Shi L, Zhu H, Lin G, Xu RA. Tang C, et al. Among authors: xu ra. Front Pharmacol. 2021 Feb 5;11:626897. doi: 10.3389/fphar.2020.626897. eCollection 2020. Front Pharmacol. 2021. PMID: 33613287 Free PMC article.

4

Identification and Enzymatic Activity Evaluation of a Novel CYP2C9 Allelic Variant Discovered in a Patient.

Zhou XY, Lu XR, Li YH, Ma YQ, Zhao SW, Wang F, Xu RA, Hu GX, Cai JP. Zhou XY, et al. Among authors: xu ra. Front Pharmacol. 2021 Feb 11;12:619339. doi: 10.3389/fphar.2021.619339. eCollection 2021. Front Pharmacol. 2021. PMID: 33643050 Free PMC article.

5

Effects of 27 CYP3A4 protein variants on saxagliptin metabolism in vitro.

Liu Q, Ou-Yang QG, Lin QM, Lu XR, Ma YQ, Li YH, Xu RA, Lin DD, Hu GX, Cai JP. Liu Q, et al. Among authors: xu ra. Fundam Clin Pharmacol. 2022 Feb;36(1):150-159. doi: 10.1111/fcp.12693. Epub 2021 Jun 6. Fundam Clin Pharmacol. 2022. PMID: 33961299

6

A Novel UPLC-MS/MS Assay for the Measurement of Linezolid and its Metabolite PNU-142300 in Human Serum and its Application to Patients With Renal Insufficiency.

Wang Y, Gu EM, Du X, Xu RA, Lin G. Wang Y, et al. Among authors: xu ra. Front Pharmacol. 2021 May 20;12:641872. doi: 10.3389/fphar.2021.641872. eCollection 2021. Front Pharmacol. 2021. PMID: 34093181 Free PMC article.

7

Characterization of Alpelisib in Rat Plasma by a Newly Developed UPLC-MS/MS Method: Application to a Drug-Drug Interaction Study.

Wang Q, Lan X, Zhao Z, Su X, Zhang Y, Zhou XY, Xu RA. Wang Q, et al. Among authors: xu ra. Front Pharmacol. 2021 Nov 25;12:743411. doi: 10.3389/fphar.2021.743411. eCollection 2021. Front Pharmacol. 2021. PMID: 34899297 Free PMC article.

8

Effect of Sophocarpine on the Pharmacokinetics of Umbralisib in Rat Plasma Using a Novel UPLC-MS/MS Method.

Weng Q, Lan X, Wang Y, Fan C, Xu RA, Zhang P. Weng Q, et al. Among authors: xu ra. Front Pharmacol. 2022 Jan 20;13:749095. doi: 10.3389/fphar.2022.749095. eCollection 2022. Front Pharmacol. 2022. PMID: 35126158 Free PMC article.

9

Effect of Baicalein on the Pharmacokinetics of Cilostazol and Its Two Metabolites in Rat Plasma Using UPLC-MS/MS Method.

Weng Q, Chen C, Xiong J, Liu YN, Pan X, Cui J, Cai JP, Xu RA. Weng Q, et al. Among authors: xu ra. Front Pharmacol. 2022 Apr 27;13:888054. doi: 10.3389/fphar.2022.888054. eCollection 2022. Front Pharmacol. 2022. PMID: 35571101 Free PMC article.

10

UPLC-MS/MS Technology for the Quantitative Methodology and Pharmacokinetic Analysis of Voxtalisib in Rat Plasma.

Li Q, Liu YN, Wang J, Hu Y, Hu J, Xu RA, Shao L, Chen L. Li Q, et al. Among authors: xu ra. Front Pharmacol. 2022 Jun 14;13:914733. doi: 10.3389/fphar.2022.914733. eCollection 2022. Front Pharmacol. 2022. PMID: 35774599 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters